- ►ucsd.edu [PDF] SJ Little, S Holte, JP Routy, ES Daar, M … - New England Journal of Medicine, 2002 - content.nejm.org Results Over the five-year period, the frequency of transmitted drug resistance
increased significantly. The frequency of high-level resistance to one or more
drugs (indicated by a value of more than 10 for the ratio of the 50 percent ... Cited by 841 - Related articles - BL Direct - All 7 versions
- ►hiv.ch [PDF] MS Hirsch, F Brun-Vézinet, RT D'Aquila, SM … - Jama, 2000 - Am Med Assoc Objective Assays for drug resistance testing in human immunodeficiency virus
type 1 (HIV-1) infection are now available and clinical studies suggest that
viral drug resistance is correlated with poor virologic response to new ... Cited by 780 - Related articles - BL Direct - All 15 versions
- ►bcpwa.org [PDF] PG Yeni, SM Hammer, CCJ Carpenter, DA … - Jama, 2002 - Am Med Assoc Evidence and Consensus Process The full panel was convened in late 2000 and
assigned 7 section committees. A section writer and 3 to 5 section committee
members (each panel member served on numerous sections) identified relevant ... Cited by 686 - Related articles - BL Direct - All 12 versions
- ►idsociety.org [PDF] MS Hirsch, F Brun-Vézinet, B Clotet, B … - Clinical Infectious Diseases, 2003 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 455 - Related articles - BL Direct - All 26 versions
- ►nih.gov CJ Petropoulos, NT Parkin, KL Limoli, YS … - Antimicrobial agents and chemotherapy, 2000 - aac.highwire.org Although combination antiretroviral therapy has resulted in a considerable
improvement in the treatment of human immunodeficiency virus (HIV) type 1
(HIV-1) infection, the emergence of resistant virus is a significant ... Cited by 426 - Related articles - BL Direct - All 10 versions
- ►sanbi.ac.za [PDF] C Tural, L Ruiz, C Holtzer, J Schapiro, P … - Aids, 2002 - journals.lww.com From the a HIV Clinical Unit and IrsiCaixa Retrovirology Laboratory, Hospital
Universitari Germans Trias i Pujol, Universitat Autónoma de Barcelona (UAB),
Badalona, Spain, b Visible Genetics, Paris, France, the c University of ... Cited by 278 - Related articles - BL Direct - All 11 versions
- ►nejm.org GD Sanders, AM Bayoumi, V Sundaram, SP … - The New England Journal of Medicine (CME), 2005 - cme.nejm.org Results Given a 1 percent prevalence of unidentified HIV infection, screening
increased life expectancy by 5.48 days, or 4.70 quality-adjusted days, at an
estimated cost of $194 per screened patient, for a cost-effectiveness ratio ... Cited by 224 - Related articles - Cached - All 17 versions
A Cingolani, A Antinori, MG Rizzo, R Murri, … - Aids, 2002 - journals.lww.com From the a Istituto di Clinica delle Malattie Infettive, Università Cattolica
del Sacro Cuore, Rome, Italy; and b Istituto Nazionale per le Malattie Infettive
'Lazzaro Spallanzani', IRCCS, Rome, Italy. ... Sponsorship: This work was ... Cited by 217 - Related articles - BL Direct - All 7 versions
- ►nih.gov RW Shafer - Clinical Microbiology Reviews, 2002 - cmr.highwire.org There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs
belonging to three mechanistic classes: protease inhibitors, nucleoside and
nucleotide reverse transcriptase (RT) inhibitors, and nonnucleoside RT ... Cited by 198 - Related articles - BL Direct - All 12 versions
- ►annals.org [PDF] MC Weinstein, SJ Goldie, E Losina, CJ Cohen … - Annals of internal medicine, 2001 - Am Coll Physicians Background: Genotypic sequencing for drug-resistant strains of HIV can guide the
choice of antiretroviral therapy. Objective: To assess the cost-effectiveness of
genotypic resis- tance testing for patients acquiring drug resistance ... Cited by 182 - Related articles - BL Direct - All 8 versions
